Prophylactic insulin treatment in relatives at high risk for type 1 diabetes
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is possible to screen newborn children to identify those at increased risk for developing type 1 diabetes (267-269).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [267]
Citations
Cites
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
Zhang, Z. J., Davidson, L., Eisenbarth, G., & Weiner, H. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10252 · Cited by 563
Shah, S. C., Malone, J., & Simpson, N. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200902 · Cited by 317
Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy
Atkinson, M. A., Maclaren, N. K., & Luchetta, R. (1990) · Diabetes · doi:10.2337/diab.39.8.933 · Cited by 299
Insulin prophylaxis in individuals at high risk of type 1 diabetes
Keller, R. J., Jackson, R. A., Eisenbarth, G. S., & Eisenbarth, G. (1993) · The Lancet · doi:10.1016/0140-6736(93)91215-8 · Cited by 298
PREDICTING INSULIN-DEPENDENT DIABETES
Tarn, A., Dean, B., Schwarz, G., Thomas, J., Ingram, D., Franco Bottazzo, G., & Gale, E. M. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91601-7 · Cited by 261
Gotfredsen, C. F., Buschard, K., & Frandsen, E. K. (1985) · Diabetologia · doi:10.1007/bf00703140 · Cited by 205
Ziegler, A. G., Ziegler, R., Vardi, P., Jackson, R. A., Soeldner, J. S., & Eisenbarth, G. S. (1989) · Diabetes · doi:10.2337/diab.38.10.1320 · Cited by 140
Self-citationPalmer, J. P., Helqvist, S., Spinas, G. A., Mølvig, J., Mandrup-Poulsen, T., Andersen, H. U., & Nerup, J. (1989) · Diabetes · doi:10.2337/diab.38.10.1211 · Cited by 129
Ziegler, A., Hillebrand, B., Rabl, W., Mayrhofer, M., Hummel, M., Mollenhauer, U., Vordemann, J., Lenz, A., & Standl, E. (1993) · Diabetologia · doi:10.1007/bf00402275 · Cited by 114
Self-citationZiegler, A. G., Herskowitz, R. D., Jackson, R. A., Soeldner, J. S., & Eisenbarth, G. S. (1990) · Diabetes Care · doi:10.2337/diacare.13.7.762 · Cited by 96
Self-citation
Research works printed but not linked: 2
- Appel MC, 1989, Beta cell activity regulates the expression of islet antigenic determinants, Diabetologia, 32, 461A
- Mollenhauer U, 1993, Insulin treatment of non‐diabetic islet cell antibody positive first degree relatives: a randomized controlled trial, J Autoimmun, 15, 63
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.436 · Cited by 1,130
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Diabetes Care · doi:10.2337/dc11-9998 · Cited by 718
Palmer, A. J., Roze, S., Valentine, W. J., Minshall, M. E., Foos, V., Lurati, F. M., Lammert, M., & Spinas, G. A. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x1980 · Cited by 526
Extrapancreatic insulin-producing cells in multiple organs in diabetes
Kojima, H., Fujimiya, M., Matsumura, K., Nakahara, T., Hara, M., & Chan, L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308690100 · Cited by 211
Can we accurately predict the development of rheumatoid arthritis in the preclinical phase?
Majka, D. S., & Holers, V. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11224 · Cited by 68
Christie, M. R., Roll, U., Payton, M. A., Hatfield, E., & Ziegler, A. (1997) · Diabetes Care · doi:10.2337/diacare.20.6.965 · Cited by 72
“Two of these 53 relatives were identified to already have overt IDDM, and 7 were entered into a prophylactic insulin trial (9).”
BackgroundSelf-citationRabinovitch, A., & Skyler, J. S. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70022-5 · Cited by 71
Narendran, P., Estella, E., & Fourlanos, S. (2005) · QJM · doi:10.1093/qjmed/hci088 · Cited by 68
Jansen, A., Rosmalen, J. G. M., Homo‐Delarche, F., Dardenne, M., & Drexhage, H. A. (1996) · Journal of Autoimmunity · doi:10.1006/jaut.1996.0046 · Cited by 44
“It has been shown that prophylactic insulin treatment of subjects at high risk of developing IDDM significantly delayed the onset of diabetes [7, 8].”
BackgroundIslet abnormalities in the pathogenesis of autoimmune diabetes
Rosmalen, J. G. M., Leenen, P. J. M., Pelegrí, C., Drexhage, H. A., & Homo‐Delarche, F. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00600-8 · Cited by 42
Yip, L., Taylor-Edwards, C., Whiting, C. C., & Fathman, C. G. (2013) · Diabetes · doi:10.2337/db13-0614 · Cited by 43
“Consistent with this idea, prevention of b-cell hyperactivity was shown to delay the onset of diabetes (47).”
BackgroundSchatz, D., Cuthbertson, D. D., Atkinson, M. A., Clare-Salzler, M. J., Winter, W. E., MUIR, A. B., Silverstein, J. H., Cook, R., Maclaren, N. K., She, J., et al. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00047.x · Cited by 44
“Had we compared the rate of progression to other models used in other small pilot studies conducted (26, 27), we too would have noted an effect, which clearly did not exist.”
ResultGraves, P. M., & Eisenbarth, G. S. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00070-2 · Cited by 35
Rodríguez-Villar, C., Conget, I., Casamitjana, R., Ercilla, G., & Gomis, R. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00044.x · Cited by 13
Hamza, S. M., Sung, M. M. Y., Gao, F., Soltys, C.-L. M., Smith, N. P., MacDonald, P. E., Light, P. E., & Dyck, J. R. B. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.11.029 · Cited by 10
Immunotherapy Trials for Type 1 Diabetes: The Contribution of George Eisenbarth
Skyler, J. S., & Pugliese, A. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0107 · Cited by 9
“Ziegler (a former Fellow of George’s) and her colleagues in Munich, Germany, initiated a similar study of prophylactic insulin use.(20) In their randomized trial, ultimately seven subjects at risk of T1D received prophylactic insulin, and seven were randomized to the control group.”
BackgroundKabadi, U. M., Reust, C. S., & Kabadi, M. U. (2000) · AIDS Patient Care and STDs · doi:10.1089/10872910050193743 · Cited by 6
Skyler, J. S. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70272-3 · Cited by 6
Kabadi, U. M., & Kabadi, M. U. (2004) · Clinical Drug Investigation · doi:10.2165/00044011-200424050-00005 · Cited by 3
Skyler, J. S. (2010) · Wiley eBooks · doi:10.1002/9780470682807.ch4 · Cited by 2
In Pursuit of Type 1 Diabetes Prevention
Marks, J. B. (2002) · Clinical Diabetes · doi:10.2337/diaclin.20.4.168 · Cited by 2
Role of IA-2 antibodies in clinical and preclinical type 1 diabetes
Savola, K. (2000) · Cited by 3
Endokrinologie und Stoffwechsel
Prange, H. W., Luft, D., Kristian, R. E. T. T., Seewi, O., Keller, C., Assmann, G., Paulus, W., Floege, J., von Eckardstein, A., Assmann, G., et al. (2000) · Springer eBooks · doi:10.1007/978-3-642-59730-5_4 · Cited by 1
Preventive Interventions for Type 1 Diabetes: History, Appraisal and Prospects
Dupre, J., Jeffrey, L., & Mahon (2007) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(07)14011-9
“In the study in Germany, through 4 to 39 months, none of the insulin-treated subjects developed diabetes, whereas 2 of the “controls” developed the disease at 5 and 8 months ( 21 ).”
BackgroundGeutskens, S. B. (2004) · RePub (Erasmus University Rotterdam)
Immunotherapy of Immune-Mediated Diabetes: Present and Future
Maclaren, N. K. (2000) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:19:3:277
The genetic basis of T and B cell contribution to autoimmune diabetes in NOD mice
Motta, V. N. (2006) · DiVA at Umeå University (Umeå University)
Brado, M., Bierhaus, A., Clemens, A., Dugi, K. A., Haass, M., Hammes, H., Herbay, A. V., Hofmann, M. A., Isermann, B., Kassessinoff, T. A., et al. (2001) · Springer eBooks · doi:10.1007/978-3-642-56784-1_16
Clemens, A., Wahl, P. M., Klöppel, G., & Nawroth, P. (1999) · Springer eBooks · doi:10.1007/978-3-642-58588-3_3
Metadata
- Authors
- Ziegler, A., Bachmann, W., & Rabl, W.
- Affiliations
- München Klinik Schwabing (DE)
- Technical University of Munich (DE)
- Corresponding author
- Ziegler, Anette‐G.
- ORCID
- Ziegler, Anette‐G.
- Venue
- Diabetes/Metabolism Reviews
- Publisher
- Wiley
- Published
- 1993-12
- Volume
- 9
- Issue
- 4
- Pages
- 289-293
- ISSN
- 0742-4221 (ISSN-L)
- 1099-0895
- OpenAlex
- W2133034713
- Cited by
- 31
- References
- 12
- Citations by year
- 2016: 1 · 2013: 2
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes/Metabolism Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, familial risk, diabetes prevention
- MeSH terms
- Animals, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Female, Humans, Insulin, Male, Autoimmunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.